By Angela Priestley The first major global pharmaceutical company dedicated to women’s health has just listed on the New York Stock Exchange, with Nirelle Tolstoshev leading the local Australian team. Organon is a newly formed Fortune 500 company that listed on the NYSE on Thursday. It’s spun off from Merck & Co, one of the world’s largest pharmaceutical businesses, and launches with…
